Lianhetech Europe Revenue and Competitors
Estimated Revenue & Valuation
- Lianhetech Europe's estimated annual revenue is currently $15M per year.
- Lianhetech Europe's estimated revenue per employee is $46,729
Employee Data
- Lianhetech Europe has 321 Employees.
- Lianhetech Europe grew their employee count by -2% last year.
Lianhetech Europe's People
Name | Title | Email/Phone |
---|---|---|
1 | Quality Control Senior Shift Analyst | Reveal Email/Phone |
Lianhetech Europe Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.7M | 41 | 5% | N/A | N/A |
#2 | $7.5M | 20 | -5% | N/A | N/A |
#3 | $3.5M | 60 | 18% | N/A | N/A |
#4 | $19M | 136 | 15% | N/A | N/A |
#5 | $1.7M | 36 | 3% | N/A | N/A |
#6 | $4.8M | 34 | -3% | N/A | N/A |
#7 | $8.8M | 63 | 2% | N/A | N/A |
#8 | $1.7M | 53 | -12% | N/A | N/A |
#9 | $15M | 176 | -6% | N/A | N/A |
#10 | $0.1M | 1 | 0% | N/A | N/A |
What Is Lianhetech Europe?
N/A
Total Funding
321
Number of Employees
$15M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lianhetech Europe News
2022-04-17 - Pharmaceutical Intermediates Market to Garner USD 37290.33 ...
... Dextra Laboratories Limited, Sanofi Winthrop Industries S.A., Vertellus Holdings LLC, BASF SE, Lianhetech, Codexis, ... Rest of Europe.
2022-04-17 - Pharmaceutical Intermediates Market insights on the post COVID-19 ...
The report presents the market size for all segments and the categories within them for regional markets, including North America, Europe,...
2022-04-13 - Global Pesticide Herbicide Market 2022 status and outlook Growth ...
BASF; Lianhetech; Limin Group; Zhejiang Xinan Chemical; Hailir Pesticides and ... France, United Kingdom, Russia, Italy, and Rest of Europe)...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $59.1M | 321 | 7% | $0.71M |
#2 | $7.5M | 321 | 5% | N/A |
#3 | $58.2M | 321 | N/A | N/A |
#4 | $64.2M | 321 | -3% | N/A |
#5 | $15M | 321 | 38% | N/A |